Back to search
FDAFDA · Food and drugs·Recall number D-0846-2022

Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2%, 100 mL per bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701, NDC 50383-775-04

Published May 11, 2022 · Recall initiated: April 15, 2022

Summary

FDA records drug Class III recall D-0846-2022, published May 11, 2022 and initiated April 15, 2022. Recalling firm: Akorn, Inc.; Status: Terminated; Reported quantity: 66,744 bottles; Lot: Lot #: 370978, Exp 9/30/2022. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed viscosity specification - product was below specificcation

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akorn, Inc.
Distributor
Nationwide USA and Puerto Rico
Lot
Lot #: 370978, Exp 9/30/2022
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2%, 100 mL per bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701, NDC 50383-775-04 recalled?

Yes. FDA published recall D-0846-2022 on May 11, 2022. Reported hazard: Failed viscosity specification - product was below specificcation

What should I do if I have this product?

Voluntary: Firm initiated · Letter